When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management. Chronic obstructive ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir ® System for the treatment of patients suffering from moderate to severe ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

Reviewed by Ware Kuschner, MD, Professor of Medicine, Division of Pulmonary, Allergy, & Critical Care Medicine, Stanford University School of Medicine Among adults with chronic obstructive pulmonary ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

An overview of COPD management programs available and offered by payers to members to help support patient adherence to chronic obstructive pulmonary disease therapies. Neil Minkoff, MD: What are the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Please provide your email address to receive an email when new articles are posted on . The PatientInsights 28-question survey from Phreesia was offered to patients with COPD in January 2025. Patients ...